Clinical Trial Update: SU011248 in Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial of SU011248 in advanced hepatocellular carcinoma has completed. The snippet does not provide results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• SU011248

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hepatocellular Carcinoma, Liver Cancer | Phase 2 | Status: COMPLETED